← Open Payments lookup

AMY STOTT: Open Payments

NPI 1427420397 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,516 in 88 payments from 15 companies in 2025. Trend: 2023 $1,607 · 2024 $1,495 · 2025 $1,516

Food & beverage: $1,516
CompanyPaymentsAmount
ABBVIE INC.32$520
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$250
Ardelyx, Inc.14$200
Janssen Biotech, Inc.4$102
Takeda Pharmaceuticals U.S.A., Inc.4$75
Phathom Pharmaceuticals, Inc.6$70
Gilead Sciences, Inc.3$65
Lilly USA, LLC3$47
Aimmune Therapeutics, Inc.2$43
GENZYME CORPORATION1$34

Products named: RINVOQ, XIFAXAN, IBSRELA, TREMFYA, MAVYRET, VOQUEZNA, VIBERZI, DUPIXENT.

Industry payments across IN — which companies pay providers there.